Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria-Reference-Cited by-同舟云学术

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria

Published:2017-01-04 Issue:4 Volume:72 Page:519-533
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Kaplan A. P.¹,Giménez-Arnau A. M.²,Saini S. S.³

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology; Department of Medicine; Medical University of South Carolina; Charleston SC USA

2. Department of Dermatology; Hospital del Mar, Institut Mar D'Investigacions Mediques; Universitat Autònoma; Barcelona Spain

3. Johns Hopkins Asthma and Allergy Center; Baltimore MD USA

Funder

Novartis Pharmaceuticals Corporation

Genentech

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13083/fullpdf

Reference144 articles.

1. The diagnosis and management of acute and chronic urticaria: 2014 update;Bernstein;J Allergy Clin Immunol,2014

2. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014

3. Chronic urticaria: pathogenesis and treatment;Kaplan;J Allergy Clin Immunol,2004

4. Late cutaneous reactions in patients with delayed pressure urticaria;Davis;J Allergy Clin Immunol,1984

5. Isolated late cutaneous skin test response to ampicillin: a distinct entity;Dolovich;J Allergy Clin Immunol,1988

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Mast Cell Activation Test as a Diagnostic Tool in Chronic Spontaneous Urticaria;International Journal of Molecular Sciences;2024-08-27

2. Omalizumab for Treatment of Anti-GD2 Antibody-Related Urticaria;Journal of Pediatric Hematology/Oncology;2024-08-22

3. Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients;Frontiers in Immunology;2024-08-20

4. Urticaria Management in North America: What We Know and What We Do Not Know;Current Treatment Options in Allergy;2024-08-06

5. Targeting inhibitory Siglec-3 to suppress IgE-mediated human basophil degranulation;Journal of Allergy and Clinical Immunology;2024-08